UPCOMING EVENTS

Held in September 2019, the aim of the symposium was to showcase the state of the art of Mass Spectrometry Imaging (MSI) in the clinical arena. Mass spectrometry imaging allows tissue to be directly probed at the molecular level while maintaining microscopic spatial distribution, good resolution and excellent reproducibility. This relatively new technology has already made a significant impact in translational science and with new protocols and solutions in the pipeline, it promises to continue to do so for years to come.

​

​During this Symposium, SCALPEL had signed a landmark research collaboration agreement with Bruker, giving us access to state of the art instruments and their vast network of application specialists.